Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients With Relapsed or Refractory Large B-Cell Lymphoma

被引：0
|
作者：
不详
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2019年 / 17卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：15 / 17
页数：3
相关论文
共 50 条
  • [31] Delayed neurotoxicity after axicabtagene ciloleucel therapy in relapsed refractory diffuse large B-cell lymphoma
    Badar, Talha
    Johnson, Bryon D.
    Hamadani, Mehdi
    BONE MARROW TRANSPLANTATION, 2021, 56 (03) : 683 - 685
  • [32] CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
    Plaks, Vicki
    Rossi, John M.
    Chou, Justin
    Wang, Linghua
    Poddar, Soumya
    Han, Guangchun
    Wang, Zixing
    Kuang, Shao-Qing
    Chu, Fuliang
    Davis, Richard E.
    Vega, Francisco
    Bashir, Zahid
    Jacobson, Caron A.
    Locke, Frederick L.
    Reagan, Patrick M.
    Rodig, Scott J.
    Lekakis, Lazaros J.
    Flinn, Ian W.
    Miklos, David B.
    Bot, Adrian
    Neelapu, Sattva S.
    BLOOD, 2021, 138 (12) : 1081 - 1085
  • [33] Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma
    Koji Kato
    Shinichi Makita
    Hideki Goto
    Junya Kanda
    Nobuharu Fujii
    Kazuyuki Shimada
    Koichi Akashi
    Koji Izutsu
    Takanori Teshima
    Natsuko Fukuda
    Tokuhito Sumitani
    Hiroyuki Sumi
    Shinji Shimizu
    Yasuyuki Kakurai
    Kenji Yoshikawa
    Kensei Tobinai
    Noriko Usui
    Kiyohiko Hatake
    International Journal of Clinical Oncology, 2022, 27 : 213 - 223
  • [34] Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma
    Kato, Koji
    Makita, Shinichi
    Goto, Hideki
    Kanda, Junya
    Fujii, Nobuharu
    Shimada, Kazuyuki
    Akashi, Koichi
    Izutsu, Koji
    Teshima, Takanori
    Fukuda, Natsuko
    Sumitani, Tokuhito
    Sumi, Hiroyuki
    Shimizu, Shinji
    Kakurai, Yasuyuki
    Yoshikawa, Kenji
    Tobinai, Kensei
    Usui, Noriko
    Hatake, Kiyohiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (01) : 213 - 223
  • [35] CAR T-cell therapy in refractory large B-cell lymphoma
    Stirrups, Robert
    LANCET ONCOLOGY, 2018, 19 (01): : E19 - E19
  • [36] Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma
    Sim, Austin J.
    Jain, Michael D.
    Figura, Nicholas B.
    Chavez, Julio C.
    Shah, Bijal D.
    Khimani, Farhad
    Lazaryan, Aleksandr
    Krivenko, Gabriel
    Davila, Marco L.
    Liu, Hien D.
    Falchook, Aaron D.
    Dahiya, Saurabh
    Rapoport, Aaron P.
    Kim, Sungjune
    Locke, Frederick L.
    Robinson, Timothy J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (05): : 1012 - 1021
  • [37] Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
    Nastoupil, Loretta J.
    Jain, Michael D.
    Feng, Lei
    Spiegel, Jay Y.
    Ghobadi, Armin
    Lin, Yi
    Dahiya, Saurabh
    Lunning, Matthew
    Lekakis, Lazaros
    Reagan, Patrick
    Oluwole, Olalekan
    McGuirk, Joseph
    Deol, Abhinav
    Sehgal, Alison R.
    Goy, Andre
    Hill, Brian T.
    Vu, Khoan
    Andreadis, Charalambos
    Munoz, Javier
    Westin, Jason
    Chavez, Julio C.
    Cashen, Amanda
    Bennani, N. Nora
    Rapoport, Aaron P.
    Vose, Julie M.
    Miklos, David B.
    Neelapu, Sattva S.
    Locke, Frederick L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (27) : 3119 - +
  • [38] Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy
    Iqbal, Madiha
    Jagadeesh, Deepa
    Chavez, Julio
    Khurana, Arushi
    Rosenthal, Allison
    Craver, Emily
    Epperla, Narendranath
    Li, Zhuo
    Isufi, Iris
    Awan, Farrukh T.
    Dholaria, Bhagirathbhai R.
    Maakaron, Joseph E.
    Sandoval-Sus, Jose D.
    Mishra, Rahul
    Saha, Aditi
    Annunzio, Kaitlin
    Bhaskar, Shakthi T.
    Sumransub, Nuttavut
    Fijalka, Andrew
    Ivanov, Stanislav A.
    Lin, Yi
    Kharfan-Dabaja, Mohamed A.
    BONE MARROW TRANSPLANTATION, 2024, 59 (02) : 211 - 216
  • [39] Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy
    Madiha Iqbal
    Deepa Jagadeesh
    Julio Chavez
    Arushi Khurana
    Allison Rosenthal
    Emily Craver
    Narendranath Epperla
    Zhuo Li
    Iris Isufi
    Farrukh T. Awan
    Bhagirathbhai R. Dholaria
    Joseph E. Maakaron
    Jose D. Sandoval-Sus
    Rahul Mishra
    Aditi Saha
    Kaitlin Annunzio
    Shakthi T. Bhaskar
    Nuttavut Sumransub
    Andrew Fijalka
    Stanislav A. Ivanov
    Yi Lin
    Mohamed A. Kharfan-Dabaja
    Bone Marrow Transplantation, 2024, 59 : 211 - 216
  • [40] Tumor gene expression signatures associated with outcome in large B-cell lymphoma treated with CD19-directed CAR T-cell therapy (axicabtagene ciloleucel)
    Tian, Yuan
    Budka, Justin
    Locke, Frederick L.
    Westin, Jason R.
    To, Christina
    Tiwari, Gayatri
    Mao, Daqin
    Bedognetti, Davide
    Shen, Rhine R.
    Andrade, Jorge
    Filosto, Simone
    FRONTIERS IN ONCOLOGY, 2025, 15
12345